Lixte Biotechnology Holdings Inc. (LIXTW)
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
Avanos Medical Inc (AVNS)
Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management
Lipocine Inc. (LPCN)
Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Eli Lilly and Company (LLY)
Lillys sofetabart mipitecan receives U.S. FDAs Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
LakeShore Biopharma Co., Ltd s (LSBPW)
RAPT Therapeutics Inc (RAPT)
Immuron Limited (IMRN)
Novavax Inc (NVAX)
Novavax Announces Entering into a License Agreement with Pfizer
RAPT Therapeutics Inc (RAPT)
CAN FITE BIO (CANF)
Cidara Therapeutics Inc. (CDTX)
NervGen Pharma Corp. (NGENF)
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
Mind Medicine (MNMD)
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Me...
CAN FITE BIO (CANF)
Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson
908 Devices Inc (MASS)
908 Devices Inc. - 908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025